Trevi Therapeutics, Inc. TRVI Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s shares (basic)?
- Trevi Therapeutics, Inc. (TRVI) reported shares (basic) of 145.6M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s shares (basic) changed year-over-year?
- Trevi Therapeutics, Inc.'s shares (basic) increased by 23.8% year-over-year, from 117.6M to 145.6M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s shares (basic)?
- Over 3 years (2022 to 2025), Trevi Therapeutics, Inc.'s shares (basic) has grown at a 33.1% compound annual growth rate (CAGR), from 223.8M to 527.8M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.